Ensysce Biosciences (ENSCW) Assets Average (2018 - 2025)

Ensysce Biosciences (ENSCW) has 8 years of Assets Average data on file, last reported at $5.3 million in Q4 2025.

• Assets Average for Q4 2025 came in at $5.3 million, down 29.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.3 million (down 29.04% YoY), and the FY2025 annual result was $6.5 million, up 57.12% from the prior year.
• Assets Average improved to $5.3 million in Q4 2025 per ENSCW's latest filing, from $4.4 million in the prior quarter.
• Over five years, Assets Average peaked at $14.4 million in Q1 2022 and troughed at $3.0 million in Q4 2023.
• A 5-year average of $7.0 million and a median of $5.7 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2021 and 2024: Assets Average tumbled 94.83% in 2021, then surged 152.78% in 2024.
• A 5-year view of Assets Average shows it stood at $13.1 million in 2021, then tumbled by 45.76% to $7.1 million in 2022, then sank by 58.19% to $3.0 million in 2023, then soared by 152.78% to $7.5 million in 2024, then decreased by 29.04% to $5.3 million in 2025.
• Business Quant data shows ENSCW's Assets Average at $5.3 million in Q4 2025, $4.4 million in Q3 2025, and $5.1 million in Q2 2025.